From: Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
hif-1α | |||||
---|---|---|---|---|---|
Parameter | n (%) | Negative | Weak | Strong | P |
Total | 77 (100) | 34 (44) | 25 (33) | 18 (23) | |
Age | |||||
<50 years | 23 (30) | 8 (35) | 10 (43) | 5 (22) | 0.38 |
>50 years | 54 (70) | 26 (48) | 15 (28) | 13 (24) | |
T stage | |||||
T1/T2 | 55 (71) | 26 (48) | 16 (30) | 13 (22) | 0.57 |
T3/T4 | 22 (29) | 8 (36) | 9 (41) | 5 (23) | |
Differentiation/grade | |||||
Moderate/G2 | 43 (56) | 20 (46) | 12 (28) | 11 (26) | 0.68 |
Poor/G3 | 32 (42) | 12 (37) | 13 (41) | 7 (22) | |
Number of lymph nodes | |||||
1–3 | 27 (35) | 14 (52) | 8 (30) | 5 (18) | 0.58 |
≥4 | 50 (65) | 20 (40) | 17 (34) | 13 (26) | |
Estrogen receptor | |||||
Positive | 51 (66) | 26 (51) | 14 (27) | 11 (22) | 0.23 |
Negative | 26 (34) | 8 (31) | 11 (42) | 7 (27) | |
Progesterone receptor | |||||
Positive | 41 (53) | 25 (61) | 9 (22) | 7 (17) | 0.006 |
Negative | 36 (47) | 9 (25) | 16 (44) | 11 (31) | |
Hormonotherapy | |||||
Yes | 62 (81) | 27(43) | 19(31) | 16(26) | 0.56 |
No | 15 (19) | 7(47) | 6(40) | 2(13) | |
Chemotherapy | |||||
Yes | 64 (83) | 25(39) | 23(36) | 16(25) | 0.13 |
No | 13 (17) | 9(69) | 2(15) | 2(15) |